Clinical Trial Update: A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing safety and clinical equivalence of two clotrimazole troche/lozenge formulations for oropharyngeal candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Candidiasis

Drugs mentioned

• Clotrimazole Troche 10 mg (clotrimazole)
• Clotrimazole Troche/Lozenges USP 10 mg (clotrimazole)

Snippet

Sponsor: Thinq Pharma-CRO Pte. Ltd. | Conditions: Oropharyngeal Candidiasis | Phase 3 | Status: UNKNOWN